Contrast-induced nephropathy: Controlled study by differential GFR measurement in hospitalized patients

Acta Radiologica

Volumn 53, Issue 2, 2012, Pages 228-232

  Erselcan, Taner ^a   Egilmez, Hulusi ^a   Hasbek, Zekiye ^a   Tandogan, Izzet ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Contrast agents; Radionuclides; Renal failure; Screening; Toxicity

Indexed keywords

CHRONIC KIDNEY DISEASE; CONTRAST AGENT; CONTROL MEASURES; MEAN AGES; NEPHROPATHY; RENAL FAILURE; STUDY GROUPS;

CONTRAST MEDIA; DIAGNOSIS; DIALYSIS; RADIOISOTOPES; SCREENING; TOXICITY;

BODY FLUIDS;

CONTRAST MEDIUM; CREATININE; DRUG DERIVATIVE; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPROMIDE; PENTETATE TECHNETIUM TC 99M;

ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL PATIENT; HUMAN; KIDNEY DISEASE; MALE; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICS; UREA NITROGEN BLOOD LEVEL;

BLOOD UREA NITROGEN; CONTRAST MEDIA; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INPATIENTS; IOHEXOL; IOPAMIDOL; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TECHNETIUM TC 99M PENTETATE;

EID: 84858832961     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1258/ar.2011.110412     Document Type: Article

References (30)

1. Katzberg RW, Haller C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int Suppl 2006;100:S3-7
2. Mehran R, Nikolsky E. Contrast-induced nephropathy: Definition, epidemiology and patients at risk. Kidney Int Suppl 2006;100:S11-5
3. Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999;9:1602-13
4. Newhouse JH, Kho D, Rao QA, et al. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. Am J Roentgenol 2008;191:376-82
5. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006;239:392-7
6. Thomsen HS, Morcos SK. Contrast media and the kidney: European society of urogenital radiology (ESUR) guidelines. Br J Radiol 2003;76:513-8 (Pubitemid 37028403)
7. Kapoor A, Kumar S, Gulati S, et al. The role of theophylline in contrast-induced nephropathy: a case-control study. Nephrol Dial Transplant 2002;17:1936-41 (Pubitemid 35277091)
8. Bader BD, Berger ED, Heede MB, et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 2004;62:1-7 (Pubitemid 38979102)
9. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39 (Suppl 1):S1-266
10. Blaufox MD, Aurell M, Bubeck B, et al. Report of the radionuclides in nephrourology committee on renal clearance. J Nucl Med 1996;37:1883-90 (Pubitemid 26378383)
11. Piepsz A, Colarinha P, Gordon I, et al. Paediatric Committee of the European Association of Nuclear Medicine. Guidelines for glomerular filtration rate determination in children. Eur J Nucl Med 2001;28: BP31-36
12. Fleming JS, Zivanovic MA, Blake GM, et al. British Nuclear Medicine Society. Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nucl Med Commun 2004;25:759-69 (Pubitemid 39099987)
13. Rosovsky MA, Rusinek H, Berenstein A, et al. High-dose administration of nonionic contrast media: a retrospective review. Radiology 1996;200:119-22 (Pubitemid 26197348)
14. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14-22 (Pubitemid 43181360)
15. Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol 2005;28(Suppl 2):3-11
16. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001;12:3-9 (Pubitemid 32095670)
17. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005;172:1461-71 (Pubitemid 40803495)
18. Rosenstock JL, Bruno R, Kim JK, et al. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol 2008;40:749-55
19. Erselcan T, Hasbek Z, Tandogan I, et al. Modification of diet in renal disease equation in the risk stratification of contrast induced acute kidney injury in hospital inpatients. Nefrologia 2009;29:397-403
20. Davidson C, Stacul F, McCullough PA, et al. Contrast medium use. Am J Cardiol 2006;98:p42K-58K
21. Laskey WK, Jenkins C, Selzer F, et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007;50:584-90
22. Nyman U, Björk J, Aspelin P, et al. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radiol 2008;49:658-67
23. Oddoze C, Morange S, Portugal H, et al. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis 2001;38:310-6
24. Andreev E, Koopman M, Arisz L. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med 1999;246:247-52 (Pubitemid 29426443)
25. Rosner MH, Bolton K. Renal function testing. Am J Kidney Dis 2006;47:174-83 (Pubitemid 41828281)
26. Harjai KJ, Raizada A, Shenoy C, et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008;101:812-9
27. Solomon R. Contrast media nephropathy-how to diagnose and how to prevent? Nephrol Dial Transplant 2007;22:1812-5 (Pubitemid 47244745)
28. Millward SF, Burbridge BE, Hartman NG, et al. Nephrotoxicity of ioxaglate and ioversol assessed by glomerular filtration rate: a pilot study. Can Assoc Radiol J 2006;47:24-9
29. Russell CD, Bischoff PG, Kontzen FN, et al. Measurement of glomerular filtration rate: Single injection plasma clearance method without urine collection. J Nucl Med1985;26:1243-7
30. Erley CM, Bader BD, Berger ED, et al. Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patients. Crit Care Med 2001;29:1544-50 (Pubitemid 32762334)